NAUT - Nautilus Biotechnology, Inc.

0.68
-0.008   -1.235%

Share volume: 312,060
Last Updated: 04-28-2025
Measuring And Control Equipment/Lab Analytical Instruments: -0.04%

PREVIOUS CLOSE
CHG
CHG%
$0.69
-0.01
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
21%
Profitability 0%
Dept financing 3%
Liquidity 50%
Performance 40%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-4.63%
1 Month
-21.02%
3 Months
-61.36%
6 Months
-75.45%
1 Year
-73.54%
2 Year
-73.23%
Key data
Stock price
$0.68
P/E Ratio 
0.00
DAY RANGE
$0.67 - $0.72
EPS 
-$0.56
52 WEEK RANGE
$0.66 - $3.09
52 WEEK CHANGE
-$73.23
MARKET CAP 
210.947 M
YIELD 
N/A
SHARES OUTSTANDING 
125.411 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-29-2025
BETA 
1.44
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$227,664
AVERAGE 30 VOLUME 
$186,212
Company detail
CEO: Sujal M. Patel
Region: US
Website: nautilus.bio
Employees: 130
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company was founded in 2016 and is headquartered in Seattle, Washington.

Recent news
loading